Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 122

1.

In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination.

Shimodaira S, Yanagisawa R, Koya T, Hirabayashi K, Higuchi Y, Sakamoto T, Togi M, Kato T Jr, Kobayashi T, Koizumi T, Koido S, Sugiyama H.

Vaccines (Basel). 2019 Sep 19;7(3). pii: E120. doi: 10.3390/vaccines7030120.

2.

Clinical Significance of Tumor-Infiltrating T Cells and Programed Death Ligand-1 in Patients with Pancreatic Cancer.

Yoshida S, Ito Z, Suka M, Bito T, Kan S, Akasu T, Saruta M, Okamoto M, Kitamura H, Fujioka S, Misawa T, Akiba T, Yanagisawa H, Sugiyama H, Koido S.

Cancer Invest. 2019;37(9):463-477. doi: 10.1080/07357907.2019.1661427. Epub 2019 Sep 18.

PMID:
31490702
3.

Characterisation of blood microbiota in patients with liver cirrhosis.

Kajihara M, Koido S, Kanai T, Ito Z, Matsumoto Y, Takakura K, Saruta M, Kato K, Odamaki T, Xiao JZ, Sato N, Ohkusa T.

Eur J Gastroenterol Hepatol. 2019 Dec;31(12):1577-1583. doi: 10.1097/MEG.0000000000001494.

4.

The Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer.

Takakura K, Kawamura A, Torisu Y, Koido S, Yahagi N, Saruta M.

Int J Mol Sci. 2019 Jul 6;20(13). pii: E3331. doi: 10.3390/ijms20133331. Review.

5.

Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1.

Ito Z, Kan S, Bito T, Horiuchi S, Akasu T, Yoshida S, Kajihara M, Hokari A, Saruta M, Yoshida N, Kobayashi M, Ohkusa T, Shimodaira S, Okamoto M, Sugiyama H, Koido S.

Oncology. 2019;97(3):135-148. doi: 10.1159/000500359. Epub 2019 Jun 19.

PMID:
31216557
6.

Gut Microbiota and Chronic Constipation: A Review and Update.

Ohkusa T, Koido S, Nishikawa Y, Sato N.

Front Med (Lausanne). 2019 Feb 12;6:19. doi: 10.3389/fmed.2019.00019. eCollection 2019. Review.

7.

Metagenomic analyses of the gut microbiota associated with colorectal adenoma.

Saito K, Koido S, Odamaki T, Kajihara M, Kato K, Horiuchi S, Adachi S, Arakawa H, Yoshida S, Akasu T, Ito Z, Uchiyama K, Saruta M, Xiao JZ, Sato N, Ohkusa T.

PLoS One. 2019 Feb 22;14(2):e0212406. doi: 10.1371/journal.pone.0212406. eCollection 2019.

8.

Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza and Upper Respiratory Infection in Patients With Inflammatory Bowel Disease.

Arihiro S, Nakashima A, Matsuoka M, Suto S, Uchiyama K, Kato T, Mitobe J, Komoike N, Itagaki M, Miyakawa Y, Koido S, Hokari A, Saruta M, Tajiri H, Matsuura T, Urashima M.

Inflamm Bowel Dis. 2019 May 4;25(6):1088-1095. doi: 10.1093/ibd/izy346.

9.

Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines.

Hanada S, Tsuruta T, Haraguchi K, Okamoto M, Sugiyama H, Koido S.

Hum Vaccin Immunother. 2019;15(2):397-406. doi: 10.1080/21645515.2018.1524238. Epub 2018 Oct 12.

10.

Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma.

Kanai T, Ito Z, Oji Y, Suka M, Nishida S, Takakura K, Kajihara M, Saruta M, Fujioka S, Misawa T, Akiba T, Yanagisawa H, Shimodaira S, Okamoto M, Sugiyama H, Koido S.

Oncol Lett. 2018 Aug;16(2):2682-2692. doi: 10.3892/ol.2018.8961. Epub 2018 Jun 13.

11.

Feasibility and Immune Response of WT1 Peptide Vaccination in Combination with OK-432 for Paediatric Solid Tumors.

Hirabayashi K, Yanagisawa R, Saito S, Higuchi Y, Koya T, Sano K, Koido S, Okamoto M, Sugiyama H, Nakazawa Y, Shimodaira S.

Anticancer Res. 2018 Apr;38(4):2227-2234.

PMID:
29599343
12.

WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study.

Yanagisawa R, Koizumi T, Koya T, Sano K, Koido S, Nagai K, Kobayashi M, Okamoto M, Sugiyama H, Shimodaira S.

Anticancer Res. 2018 Apr;38(4):2217-2225.

PMID:
29599342
13.

Combination Gemcitabine and WT1 Peptide Vaccination Improves Progression-Free Survival in Advanced Pancreatic Ductal Adenocarcinoma: A Phase II Randomized Study.

Nishida S, Ishikawa T, Egawa S, Koido S, Yanagimoto H, Ishii J, Kanno Y, Kokura S, Yasuda H, Oba MS, Sato M, Morimoto S, Fujiki F, Eguchi H, Nagano H, Kumanogoh A, Unno M, Kon M, Shimada H, Ito K, Homma S, Oka Y, Morita S, Sugiyama H.

Cancer Immunol Res. 2018 Mar;6(3):320-331. doi: 10.1158/2326-6066.CIR-17-0386. Epub 2018 Jan 22.

14.

Fatty Acids as Useful Serological Markers for Crohn's Disease.

Ito Z, Uchiyama K, Odahara S, Takami S, Saito K, Kobayashi H, Koido S, Kubota T, Ohkusa T, Saruta M.

Dig Dis. 2018;36(3):209-217. doi: 10.1159/000485096. Epub 2017 Dec 22.

PMID:
29275413
15.

Encryption of agonistic motifs for TLR4 into artificial antigens augmented the maturation of antigen-presenting cells.

Ito M, Hayashi K, Minamisawa T, Homma S, Koido S, Shiba K.

PLoS One. 2017 Nov 30;12(11):e0188934. doi: 10.1371/journal.pone.0188934. eCollection 2017.

16.

Significance of Wilms' tumor 1 antigen as a cancer vaccine for pancreatic cancer.

Koido S, Okamoto M, Kobayashi M, Shimodaira S, Sugiyama H.

Discov Med. 2017 Aug;24(130):41-49. Review.

17.

Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma.

Ito Z, Takakura K, Suka M, Kanai T, Saito R, Fujioka S, Kajihara M, Yanagisawa H, Misawa T, Akiba T, Koido S, Ohkusa T.

Oncol Lett. 2017 Jun;13(6):4799-4805. doi: 10.3892/ol.2017.6071. Epub 2017 Apr 21.

18.

Wilms' tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancer.

Koido S, Okamoto M, Shimodaira S, Sugiyama H.

Immunotherapy. 2016 Nov;8(11):1309-1320. Review.

PMID:
27993090
19.

Hepatic Angiosarcoma Associated with Esophageal Variceal Hemorrhage.

Ito Z, Kajihara M, Kobayashi Y, Kanai T, Matsumoto Y, Takakura K, Yukawa T, Ohkusa T, Koyama S, Imazu H, Arakawa H, Ohata M, Koido S.

Case Rep Gastroenterol. 2016 Aug 12;10(2):440-445. eCollection 2016 May-Aug.

20.

Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma.

Akasaki Y, Kikuchi T, Homma S, Koido S, Ohkusa T, Tasaki T, Hayashi K, Komita H, Watanabe N, Suzuki Y, Yamamoto Y, Mori R, Arai T, Tanaka T, Joki T, Yanagisawa T, Murayama Y.

Cancer Immunol Immunother. 2016 Dec;65(12):1499-1509. Epub 2016 Sep 29.

PMID:
27688162

Supplemental Content

Loading ...
Support Center